Home › SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes
 

Keywords :   


SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes

2015-02-04 06:58:30| drugdiscoveryonline Home Page

SinuSys Corp., an innovative sinus health company, recently announced commencement of a new clinical trial studying its proprietary drug-eluting spacer infused with steroids for use following functional endoscopic sinus surgery (FESS)

Tags: support designed study improve

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05TSCRA Disaster Relief Fund distributes $900,000 in financial assistance
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
More »